Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gopal N Gupta

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Frontiers in Cellular and Infection Microbiology|April 24, 2023
Impact of intravesical Bacillus Calmette-Guérin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancerChristopher James, Kayeromi Gomez, Shalin Desai, et al.
Journal of Robotic Surgery|January 12, 2024
Robotic versus open radical cystectomy for bladder cancer: evaluation of complications, survival, and opioid prescribing patternsRachel Yang, Goran Rac, Michael D Felice, et al.
Urologic Oncology|February 11, 2022
Survival of nonseminomatous germ cell tumors in pediatric patients and young adults - A stage group stratified analysisArnav Srivastava, Hiren V Patel, Elizabeth Koehne, et al.
The Journal of Biological Chemistry|February 26, 2015
Alcohol inhibits osteopontin-dependent transforming growth factor-β1 expression in human mesenchymal stem cellsJoseph Driver, Cynthia E Weber, John J Callaci, et al.
European Urology Focus|July 30, 2017
Functional Comparison of Renal Tumor Enucleation Versus Standard Partial NephrectomyWen Dong, Gopal N Gupta, Robert H Blackwell, et al.
Molecular Oncology|September 27, 2023
Urinary comprehensive genomic profiling predicts urothelial carcinoma recurrence and identifies responders to intravesical therapyGoran Rac, Hiten D Patel, Christopher James, et al.
Cancer|July 12, 2022
Multi-institutional analysis of clinical and imaging risk factors for detecting clinically significant prostate cancer in men with PI-RADS 3 lesionsAndrew M Fang, Luke A Shumaker, Kimberly D Martin, et al.
Urology Practice|February 18, 2026
Ten-Year Experience Transitioning from MRI-guided Transrectal to Transperineal Prostate Biopsies at a Large Single-Institution Academic CenterChris Du, Rohan Sethi, Timothy M Han, et al.
Lancet (London, England)|July 7, 2018
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trialDipen J Parekh, Isildinha M Reis, Erik P Castle, et al.
Journal of the National Cancer Institute|September 26, 2025
Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging-targeted prostate biopsy grade groups are discordantSimone Scuderi, , Amy L Tin, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Frontiers in Cellular and Infection Microbiology|April 24, 2023
Impact of intravesical Bacillus Calmette-Guérin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancerChristopher James, Kayeromi Gomez, Shalin Desai, et al.
Journal of Robotic Surgery|January 12, 2024
Robotic versus open radical cystectomy for bladder cancer: evaluation of complications, survival, and opioid prescribing patternsRachel Yang, Goran Rac, Michael D Felice, et al.
Urologic Oncology|February 11, 2022
Survival of nonseminomatous germ cell tumors in pediatric patients and young adults - A stage group stratified analysisArnav Srivastava, Hiren V Patel, Elizabeth Koehne, et al.
The Journal of Biological Chemistry|February 26, 2015
Alcohol inhibits osteopontin-dependent transforming growth factor-β1 expression in human mesenchymal stem cellsJoseph Driver, Cynthia E Weber, John J Callaci, et al.
European Urology Focus|July 30, 2017
Functional Comparison of Renal Tumor Enucleation Versus Standard Partial NephrectomyWen Dong, Gopal N Gupta, Robert H Blackwell, et al.
Molecular Oncology|September 27, 2023
Urinary comprehensive genomic profiling predicts urothelial carcinoma recurrence and identifies responders to intravesical therapyGoran Rac, Hiten D Patel, Christopher James, et al.
Cancer|July 12, 2022
Multi-institutional analysis of clinical and imaging risk factors for detecting clinically significant prostate cancer in men with PI-RADS 3 lesionsAndrew M Fang, Luke A Shumaker, Kimberly D Martin, et al.
Urology Practice|February 18, 2026
Ten-Year Experience Transitioning from MRI-guided Transrectal to Transperineal Prostate Biopsies at a Large Single-Institution Academic CenterChris Du, Rohan Sethi, Timothy M Han, et al.
Lancet (London, England)|July 7, 2018
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trialDipen J Parekh, Isildinha M Reis, Erik P Castle, et al.
Journal of the National Cancer Institute|September 26, 2025
Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging-targeted prostate biopsy grade groups are discordantSimone Scuderi, , Amy L Tin, et al.
Pageof 12